Physician profile
Xiaobin Yi
NPI 1407888498
$5,622.61
in general payments reported to CMS, 2019-2025
15 companies · $1,405 in 2025
The $1,405 reported for 2025 was more than what 75% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $762 · 2020: $42.59 · 2021: $305 · 2022: $1,352 · 2023: $1,128 · 2024: $630 · 2025: $1,405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,162.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,558.11 | 2022-2025 | Intracept |
| Medtronic, INC. | $1,020.48 | 2022-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Abbott Laboratories | $665.36 | 2019-2025 | Proclaim, Eterna |
| Spr Therapeutics, INC | $493.69 | 2021-2025 | Sprint Pns System |
| Saluda Medical Americas, INC. | $459.33 | 2023-2025 | Evoke Scs, Evoke |
| Nevro Corp. | $406.52 | 2019-2021 | |
| Medtronic USA, INC. | $248.23 | 2019 | |
| Biotronik Nro, INC. | $176.13 | 2025 | Prospera |
| Globus Medical, INC. | $152.90 | 2025 | Senza |
| Pacira Pharmaceuticals Incorporated | $136.78 | 2019-2025 | Zilretta, Iovera |
| Abbvie INC. | $118.68 | 2024-2025 | |
| Vertos Medical, INC. | $94.19 | 2019 | |
| Flowonix Medical Incorporated | $45.49 | 2019-2020 | |
| Stryker Corporation | $28.35 | 2019 | |
| Nalu Medical, INC. | $18.37 | 2023 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaobin Yi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.